Clinical Trial Update: Clinical Study of Mitoxantrone Hydrochloride Liposome Combined with PD-1 Blockade in Recurrent or Metastatic NPC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating mitoxantrone hydrochloride liposome combined with a PD-1 inhibitor for recurrent or metastatic nasopharyngeal carcinoma, currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Mitoxantrone hydrochloride liposome (Mitoxantrone hydrochloride liposome)
• PD-1 inhibitor

Snippet

Sponsor: Ming-Yuan Chen | Conditions: Recurrent or Metastatic Nasopharyngeal Carcinoma | Phase 2 | Status: RECRUITING